BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25920909)

  • 21. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
    Fukumoto T; Watanabe T; Hirai I; Kimura W
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer.
    Malleo G; Maggino L; Capelli P; Gulino F; Segattini S; Scarpa A; Bassi C; Butturini G; Salvia R
    J Am Coll Surg; 2015 Aug; 221(2):367-79.e4. PubMed ID: 26081176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
    Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
    Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.
    Renz BW; Khalil PN; Mikhailov M; Graf S; Schiergens TS; Niess H; Boeck S; Heinemann V; Hartwig W; Werner J; Bruns CJ; Kleespies A
    Int J Surg; 2016 Apr; 28():118-25. PubMed ID: 26906329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of resection for ductal adenocarcinoma of the pancreatic head].
    Morin B; Chiche L; Salame E; Lebreton G; Rouleau V; Segol P
    Ann Chir; 2006 Nov; 131(9):518-23. PubMed ID: 17045233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
    Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
    Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
    Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
    Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Pugalenthi A; Protic M; Gonen M; Kingham TP; Angelica MI; Dematteo RP; Fong Y; Jarnagin WR; Allen PJ
    J Surg Oncol; 2016 Feb; 113(2):188-93. PubMed ID: 26678349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8
    Yamaki S; Yanagimoto H; Tsuta K; Ryota H; Kon M
    Int J Clin Oncol; 2017 Aug; 22(4):726-733. PubMed ID: 28314962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
    Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
    Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
    Marsoner K; Langeder R; Csengeri D; Sodeck G; Mischinger HJ; Kornprat P
    Wien Klin Wochenschr; 2016 Aug; 128(15-16):566-72. PubMed ID: 27363995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience).
    El Nakeeb A; El Shobary M; El Dosoky M; Nabeh A; El Sorogy M; El Eneen AA; abu Zeid M; Elwahab MA
    Hepatogastroenterology; 2014; 61(133):1426-38. PubMed ID: 25436321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing survival after pancreatoduodenectomy for ductal adenocarcinoma depend on patients' age.
    Urbonas K; Gulbinas A; Smailyte G; Pranys D; Jakstaite A; Pundzius J; Barauskas G
    Dig Surg; 2015; 32(1):60-67. PubMed ID: 25721397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
    Nanashima A; Tobinaga S; Abo T; Hatano K; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
    Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
    Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA
    Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study.
    Lovecek M; Skalicky P; Klos D; Bebarova L; Neoral C; Ehrmann J; Zapletalova J; Svebisova H; Vrba R; Stasek M; Yogeswara T; Havlik R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):280-6. PubMed ID: 27029600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.